Suraksha Diagnostic logo

Suraksha Diagnostic

SURAKSHA NSE

Key Fundamentals

MicrocapHealthcare Service ProviderHealthcare Services
Market Cap
₹1,657 Cr
Volatility
Moderate
P/E Ratio
47.06
EBITDA
₹98.60 Cr
Return on Equity
12.9%
Debt to Equity
0.53
Book Value
₹47.01
52W High
₹349
52W Low
₹224.1

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has delivered good profit growth of 31.8% CAGR over last 5 years

Growth Rate

Revenue Growth
22.55% higher than 3Y
Net Income Growth
1.29% lower than 3Y
Cash Flow Change
29.15% lower than 3Y
ROE
-12.48% lower than 3Y
ROCE
-14.14% lower than 3Y
EBITDA Margin (Avg.)
-5.47% lower than 3Y

Quarterly Results

Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
60
52
55
61
67
60
65
73
79
78
81
88
Expenses
39
36
36
40
44
41
46
49
55
55
57
57
Operating Profit
21
15
19
21
23
18
19
24
24
23
24
30
OPM %
35%
30%
35%
34%
35%
31%
29%
33%
31%
30%
30%
35%
Other Income
1
1
0
1
1
1
1
1
1
1
1
1
Interest
2
2
2
2
2
2
2
3
3
3
4
4
Depreciation
8
8
8
9
9
9
9
9
10
11
11
11
PBT
11
6
9
11
14
8
9
12
12
10
10
17
Tax %
24%
27%
32%
27%
26%
26%
22%
26%
27%
28%
38%
22%
Net Profit
8
5
6
8
10
6
7
9
9
7
6
13
EPS in Rs
122
67.39
94.49
1.84
2.4
1.18
1.42
1.8
1.73
1.44
1.21
2.5
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
158
140
223
190
219
252
310
325
Expenses
123
115
174
143
146
170
214
223
Operating Profit
34
25
49
47
73
82
96
102
OPM %
22%
18%
22%
25%
33%
33%
31%
31%
Other Income
2
-1
1
1
1
4
3
3
Interest
2
2
2
10
10
9
13
14
Depreciation
13
16
15
32
33
35
41
43
PBT
21
6
33
7
31
41
45
49
Tax %
28%
-1%
28%
10%
26%
25%
30%
—
Net Profit
15
6
24
6
23
31
31
35
EPS in Rs
220
93.33
344
94.49
342
6.11
6.18
6.88
Div. Payout %
0%
0%
0%
0%
0%
0%
1%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7
7
7
7
7
10
10
Reserves
111
118
141
147
171
201
234
Borrowings
13
18
21
99
92
89
130
Other Liabilities
42
28
32
28
30
33
73
Total Liabilities
173
171
201
281
300
334
448
Fixed Assets
128
119
119
195
212
223
315
CWIP
0
0
1
2
1
11
37
Investments
5
5
0
0
0
1
0
Other Assets
39
46
80
84
87
99
97
Total Assets
173
171
201
281
300
334
448
Figures in ₹ Crores

Cash Flow

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
31
24
42
44
60
63
82
Investing
-20
-28
-44
-21
-35
-40
-52
Financing
-10
3
1
-24
-25
-24
-29
Net Cash Flow
1
-1
0
-1
0
0
1
Free Cash Flow
15
8
23
32
18
21
15
CFO/OP
111
100
95
109
95
90
99
Figures in ₹ Crores

Ratios

Particulars Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
14
16
12
9
15
20
27
Inventory Days
93
62
38
82
89
100
81
Days Payable
227
177
84
187
193
169
209
Cash Conversion Cycle
-120
-99
-34
-96
-89
-49
-101
Working Capital Days
-35
-19
-15
-49
-37
-23
-28
ROCE %
—
8%
24%
9%
17%
18%
17%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Suraksha Diagnostic insights

51 extracted metrics + investor summaries across FY20–FY26.

Log in — free

Shareholding Pattern

Others2.26%Promot.49.10%Public11.94%FIIs13.47%DIIs23.23%As ofJun 2026
0.10% of promoter holding pledged as of Jun 2026

Documents

Frequently Asked Questions about Suraksha Diagnostic

What does Suraksha Diagnostic Ltd do?
Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]
Where is Suraksha Diagnostic Ltd (SURAKSHA) listed?
Suraksha Diagnostic Ltd trades as SURAKSHA on the NSE and under code 544293 on the BSE.
Which sector does Suraksha Diagnostic Ltd belong to?
Suraksha Diagnostic Ltd is classified under the Healthcare sector, in the Healthcare Services industry.
What is the market capitalisation of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd has a market capitalisation of ₹1,657 Cr, which places it in the Small Cap band.
What is the PE ratio of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd trades at a PE ratio of 47.06, against a book value of ₹47.01 per share.
What is the 52-week high and low of Suraksha Diagnostic Ltd?
Over the last 52 weeks Suraksha Diagnostic Ltd has traded between ₹224.1 and ₹349.
Does Suraksha Diagnostic Ltd pay dividends?
Suraksha Diagnostic Ltd has a dividend yield of 0.15%.
What is the Return on Equity (ROE) of Suraksha Diagnostic Ltd?
Suraksha Diagnostic Ltd reported a return on equity of 12.90%. Its debt-to-equity ratio is 0.53.

Company Information

Incorporated in 2005, Suraksha Diagnostic offers an integrated pathology, radiology testing, and medical consultancy services solution.[1]

Website surakshanet.com
Listed 2024-12-06
Face Value ₹ 2
Issued Size 5,20,80,758

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/SURAKSHA.md for Suraksha Diagnostic Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List